Brachytherapy Afterloader System from China
High-dose rate brachytherapy device delivering Iridium-192 sources directly into tumors for precise radiation therapy. Used in nonprofit cancer centers for prostate and gynecological treatments. Qualifies under HTS 9810.00.80.00 as integral radioactive therapeutic apparatus.
Duty Rate — China → United States
12.5%
Rate breakdown
9903.05.3112.5%Section 301 (forced labor) — additional 12.5% ad valorem on products of China
Import Tips
• Include NRC/AEC source material license and institutional radiation safety plan
• Document apparatus design confirming integral radioactive source delivery mechanism
• Maintain records proving exclusive therapeutic use in nonprofit institutions